AlphaStocks
3.7
Weak

BOSTON SCIENTIFIC CORP (BSX)

Health Care / Health Care Equipment

S&P 500

$56.01

Scores poorly across most models. Proceed with caution.

Weak

Score based on 5 of 5 models — high confidence

#906out of 1126 in Health Care

Is BOSTON SCIENTIFIC CORP a Good Investment in 2026?

BOSTON SCIENTIFIC CORP (BSX) scores 3.7 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates BOSTON SCIENTIFIC CORP as Strong (8/9). However, the Graham model rates it Caution — Significantly above fair value. BOSTON SCIENTIFIC CORP currently trades above its estimated fair value of $44, suggesting limited upside at current prices. BOSTON SCIENTIFIC CORP ranks #906 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E28.9ROE12.2Market Cap84B

Estimated Fair Value

$44.4226% above

Trading slightly above estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

8/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

PEG 2.5 · Stalwart

Greenblatt

Neutral

Top 25% (rank 23%)

Frequently Asked Questions

Is BOSTON SCIENTIFIC CORP (BSX) a good investment?
Based on AlphaStocks' composite analysis, BOSTON SCIENTIFIC CORP (BSX) scores 3.7 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading slightly above estimated fair value.
What is BOSTON SCIENTIFIC CORP's Piotroski F-Score?
BOSTON SCIENTIFIC CORP's Piotroski F-Score status is Strong. The raw score is 8/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is BSX overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $44, BSX appears overvalued. The stock currently trades 26% above its estimated fair value. Trading slightly above estimated fair value.
How does BSX compare to other Health Care stocks?
BOSTON SCIENTIFIC CORP ranks #906 out of 1126 stocks in the Health Care sector, placing it in the top 80% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about BSX?
AlphaStocks evaluates BSX using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 3.7/10.

Similar Stocks

PARRAZNFTI

Compare BSX with

BSX vs PARRBSX vs AZNBSX vs FTI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer